Consultar de inmediato a un profesional de la salud ante sntomas como dolor abdominal intenso, vmitos persistentes, deshidratacin, disminucin de la produccin de orina, alteraciones visuales, desmayos o hipoglucemia
El uso de medicamentos GLP-1 requiere una relacin entre el paciente y el proveedor que incluya seguimiento peridico para garantizar su seguridad y eficacia
That flexibility is a feature of compounding, and it is also why you should never assume your vial matches a friend's or an older one of your own
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
Your results depend on factors including your starting weight, medical conditions, nutrition, physical activity, adherence to treatment, and individual response to therapy
Tirzepatide is not recommended for people with specific histories such as medullary thyroid carcinoma or MEN2